What Boehringer sees in Genelabs

By BC Staff | Jun 1, 1993 | 7:00 AM GMT

What Boehringer sees in Genelabs Genelabs Technologies Inc. (GNLB) also raised its stature as a hepatitis play when Boehringer Mannheim America Ltd. became its second non-exclusive licensee in efforts to develop products to diagnose and screen hepatitis X virus (HXV). Boehringer has paid

Read the full 471 word article

How to gain access

Continue reading with a
two-week free trial.